Cel Sci Corporation (CVM)

[Dr. Johnny Fever]

I'm 1 and 1. I did quite well on Titan Pharma, TTNP, when they received FDA approval for Probuphine, and then got out. Then I sank a lot of my earnings into NVAX, and lost my shirt. I've been following CVM for almost 10 years, and really hoping (for the science and the patients as much as for the profit) that CVM hits it out of the park.

I am also of the opinion that AVDL will be a low-risk investment into 2022, with recent FDA acceptance of their NDA for FT218, and the PDUFA date set for Oct. 15th. You might look into it, do some DD. I would like to take some profit from CVM and put it there.